Single Nucleotide Polymorphisms As Markers of Genetic Susceptibility for Oral Potentially Malignant Disorders Risk: Review of Evidence to Date

Overview

Journal Oral Oncol

Publisher Elsevier

Specialty Dentistry

Date 2016 Oct 1

PMID 27688118

Citations 14

Authors

Krithiga Shridhar

Aastha Aggarwal

Gagandeep Kaur Walia

Smriti Gulati

A V Geetha

D Prabhakaran

Preet K Dhillon

Preetha Rajaraman

Affiliations

Soon will be listed here.

Abstract

Background: Oral cancers are preceded by oral potentially malignant disorders (OPMD). Understanding genetic susceptibility for OPMD risk could provide an opportunity for risk assessment of oral cancer through early disease course. We conducted a review of single nucleotide polymorphism (SNP) studies for OPMD risk.

Methods: We identified all relevant studies examining associations of SNPs with OPMD (leukoplakia, erythroplakia and oral sub-mucous fibrosis) conducted world-wide between January, 2000 and February, 2016 using a combined keyword search on PubMed. Of these, 47 studies that presented results as odds ratios and 95% CI were considered for full review.

Results: The majority of eligible studies that explored candidate gene associations for OPMD were small (N<200 cases), limiting their scope to provide strong inference for any SNP identified to date in any population. Commonly studied SNPs were genes of carcinogen metabolism (n=18 studies), DNA repair (n=11 studies), cell cycle control (n=8 studies), extra-cellular matrix alteration (n=8 studies) and immune-inflammatory (n=6 studies) pathways. Based on significant associations as reported by two or more studies, suggestive markers included SNPs in GSTM1 (null), CCND1 (G870A), MMP3 (-1171; promotor region), TNFα (-308; rs800629), XPD (codon 751) and Gemin3 (rs197412) as well as in p53 (codon 72) in Indian populations. However, an equal or greater number of studies reported null or mixed associations for SNPs in GSTM1 (null), p53 (codon 72), XPD (codon 751), XRCC (rs25487 C/T), GSTT1 (null) and CYP1A1m1 (MspI site).

Conclusion: Candidate gene association studies have not yielded consistent data on risk loci for OPMD. High-throughput genotyping approaches for OPMD, with concurrent efforts for oral cancer, could prove useful in identifying robust risk-loci to help understand early disease course susceptibility for oral cancer.

Citing Articles

Quantum leap in the diagnosis of oral potentially malignant disorders - A review of literature.

Kokane G, Kharkar V, Kalsi H, Wagh A, Kolte D, Kumar B Natl J Maxillofac Surg. 2025; 15(3):360-366.

PMID: 39830482 PMC: 11737574. DOI: 10.4103/njms.njms_132_23.

Polymorphisms in nanog are associated with oral leukoplakia: case-control study.

Michels A, Scheifer S, Tiboni F, Modolo F, Dos Santos E, Scariot R Odontology. 2024; .

PMID: 39714583 DOI: 10.1007/s10266-024-01044-7.

Association of Methylenetetrahydrofolate Reductase rs1801133 Gene Polymorphism with Cancer Risk and Septin 9 Methylation in Patients with Colorectal Cancer.

Huang Y, Su T, Duan Q, Wei X, Fan X, Wan J J Gastrointest Cancer. 2024; 55(2):778-786.

PMID: 38252186 PMC: 11186932. DOI: 10.1007/s12029-024-01020-y.

Role of toll-like receptor in the pathogenesis of oral cancer.

Bhardwaj A, Prasad D, Mukherjee S Cell Biochem Biophys. 2023; 82(1):91-105.

PMID: 37853249 DOI: 10.1007/s12013-023-01191-8.

Systematic evaluation of TP53 codon 72 polymorphism associated with onset and progression of oral potentially malignant disorders.

Li H, Liu Y, Zhou S, Zhou Q, Yang X BMC Oral Health. 2023; 23(1):659.

PMID: 37697274 PMC: 10496165. DOI: 10.1186/s12903-023-03316-0.

References

Wu S, Chen Y, Shieh T, Chen C, Wang Y, Lee K . Association study between novel CYP26 polymorphisms and the risk of betel quid-related malignant oral disorders. ScientificWorldJournal. 2015; 2015:160185. PMC: 4369936. DOI: 10.1155/2015/160185. View

Chaudhary A, Pandya S, Mehrotra R, Bharti A, Jain S, Singh M . Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population. Biomarkers. 2010; 15(8):684-92. DOI: 10.3109/1354750X.2010.511267. View

Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia K, Chen J . Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol. 2009; 11(2):165-73. DOI: 10.1016/S1470-2045(09)70335-3. View

Johansson M, Roberts A, Chen D, Li Y, Delahaye-Sourdeix M, Aswani N . Using prior information from the medical literature in GWAS of oral cancer identifies novel susceptibility variant on chromosome 4--the AdAPT method. PLoS One. 2012; 7(5):e36888. PMC: 3360735. DOI: 10.1371/journal.pone.0036888. View

Sikdar N, Paul R, Roy B . Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers. Int J Cancer. 2004; 109(1):95-101. DOI: 10.1002/ijc.11610. View

Hsu H, Yang Y, Shieh T, Chen C, Kao Y, Yang C . Role of cytokine gene (interferon-γ, transforming growth factor-β1, tumor necrosis factor-α, interleukin-6, and interleukin-10) polymorphisms in the risk of oral precancerous lesions in Taiwanese. Kaohsiung J Med Sci. 2014; 30(11):551-8. DOI: 10.1016/j.kjms.2014.09.003. View

Ye Y, Lippman S, Lee J, Chen M, Frazier M, Spitz M . Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions. Cancer. 2008; 113(9):2488-95. PMC: 2577230. DOI: 10.1002/cncr.23854. View

Bessell A, Glenny A, Furness S, Clarkson J, Oliver R, Conway D . Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment. Cochrane Database Syst Rev. 2011; (9):CD006205. DOI: 10.1002/14651858.CD006205.pub3. View

Button K, Ioannidis J, Mokrysz C, Nosek B, Flint J, Robinson E . Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013; 14(5):365-76. DOI: 10.1038/nrn3475. View

10.

Lingen M, Pinto A, Mendes R, Franchini R, Czerninski R, Tilakaratne W . Genetics/epigenetics of oral premalignancy: current status and future research. Oral Dis. 2011; 17 Suppl 1:7-22. DOI: 10.1111/j.1601-0825.2011.01789.x. View

11.

Huang M, Spitz M, Gu J, Lee J, Lin J, Lippman S . Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis. 2006; 27(10):2034-7. DOI: 10.1093/carcin/bgl048. View

12.

Lin Y, Huang H, Wang L, Tsai C, Lung O, Dai C . Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population. Oral Oncol. 2008; 44(8):798-804. DOI: 10.1016/j.oraloncology.2007.10.006. View

13.

Guha N, Warnakulasuriya S, Vlaanderen J, Straif K . Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control. Int J Cancer. 2013; 135(6):1433-43. DOI: 10.1002/ijc.28643. View

14.

Agrawal D, Gupta S, Agarwal D, Gupta O, Agarwal M . Role of GSTM1 and GSTT1 polymorphism: susceptibility to oral submucous fibrosis in the North Indian population. Oncology. 2011; 79(3-4):181-6. DOI: 10.1159/000318533. View

15.

Ghosh T, Gupta S, Bajpai P, Agarwal D, Agarwal M, Gupta O . Association of CYP1A1, GSTM1, and GSTT1 gene polymorphism with risk of oral submucous fibrosis in a section of North Indian population. Mol Biol Rep. 2012; 39(10):9383-9. DOI: 10.1007/s11033-012-1802-x. View

16.

Babron M, Kazma R, Gaborieau V, McKay J, Brennan P, Sarasin A . Genetic variants in DNA repair pathways and risk of upper aerodigestive tract cancers: combined analysis of data from two genome-wide association studies in European populations. Carcinogenesis. 2014; 35(7):1523-7. DOI: 10.1093/carcin/bgu075. View

17.

Huang S, Chang P, Liu C, Lin M, Hsia K . O6-methylguanine-DNA methyltransferase gene coding region polymorphisms and oral cancer risk. J Oral Pathol Med. 2010; 39(8):645-50. DOI: 10.1111/j.1600-0714.2009.00880.x. View

18.

Duarte E, Ribeiro D, Gomez M, Ramos-Jorge M, Gomez R . Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression. Anticancer Res. 2008; 28(2A):1101-6. View

19.

Chiu C, Chang M, Chiang C, Hahn L, Hsieh L, Chen C . Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis. Cancer Epidemiol Biomarkers Prev. 2002; 11(7):646-53. View

20.

Radoi L, Luce D . A review of risk factors for oral cavity cancer: the importance of a standardized case definition. Community Dent Oral Epidemiol. 2012; 41(2):97-109, e78-91. DOI: 10.1111/j.1600-0528.2012.00710.x. View